Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the efficacy and safety of a routine individualized antiplatelet therapy after coronary stent implantation by evaluating "on-treatment" platelet reactivity with Multiple Electrode Aggregometry (MEA, Multiplate® Analyzer).

IDEAL-PCI Extended is the continuation of the IDEAL-PCI registry with additional focus on bleeding events and net clinical benefit


Clinical Trial Description

Determination of platelet reactivity in patients with percutaneous coronary Intervention as described in the IDEAL-PCI registry.

In the IDEAL-PCI Extended Registry an additional deescalation arm with reduction of the standard dual antiplatelet therapy (DAPT) dosis in case of low platelet reactivity to P2Y12 Inhibition or Aspirin with or without bleeding is implemented. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02974777
Study type Interventional
Source Kaiser Franz Josef Hospital
Contact
Status Withdrawn
Phase Phase 4
Completion date January 2017

See also
  Status Clinical Trial Phase
Completed NCT04206176 - The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease Phase 1/Phase 2
Completed NCT02979158 - Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass N/A
Withdrawn NCT03338660 - Platelet Function With Various Storage Techniques Phase 2
Completed NCT03603249 - Trimetazidine as an Adjunct to Enhance Clopidogrel Response. Phase 2
Completed NCT03111420 - Study of AggreGuide A-100 (ADP) Assay N/A
Recruiting NCT03005704 - Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets N/A
Recruiting NCT06228820 - Aspirin Resistance in Trinidad. Phase 2
Completed NCT04342819 - The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study. Phase 2/Phase 3
Completed NCT03121898 - PLATelet Function Operating Room Monitoring
Active, not recruiting NCT03787927 - Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets Phase 1/Phase 2